Selected research
Industry Research
Ovarian Tissue Cryopreservation Service Industry Research Report 2026
Market perspective
The global Ovarian Tissue Cryopreservation Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Ovarian Tissue Cryopreservation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Ovarian Tissue Cryopreservation Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Ovarian Tissue Cryopreservation Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Ovarian Tissue Cryopreservation Service include Cambridge University Hospitals, Lurie Children's, Newlife IVF, Cancer Council, Avisena Healthcare, Kofinas Fertility Group, Loma Linda University Center for Fertility & IVF, Livestrong and Melbourne IVF, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Ovarian Tissue Cryopreservation Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Ovarian Tissue Cryopreservation Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Ovarian Tissue Cryopreservation Service Market by Company
Cambridge University Hospitals
Lurie Children's
Newlife IVF
Cancer Council
Avisena Healthcare
Kofinas Fertility Group
Loma Linda University Center for Fertility & IVF
Livestrong
Melbourne IVF
St. Luke's Medical Centre
Manhattan Reproductive Surgery Center
Biomedical Research Centre
Guy's and St Thomas' Private Healthcare
ReproTech
Ovarian Tissue Cryopreservation Service Segment by Type
Ovary Tissue Removal
Ovarian Tissue Cryopreservation
Ovarian Tissue Reimplantation
Ovarian Tissue Cryopreservation Service Segment by Application
Individual
Family
Ovarian Tissue Cryopreservation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovarian Tissue Cryopreservation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ovarian Tissue Cryopreservation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovarian Tissue Cryopreservation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ovarian Tissue Cryopreservation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ovary Tissue Removal
- Ovarian Tissue Cryopreservation
- Ovarian Tissue Reimplantation
Applications
- Individual
- Family
Companies covered
- Cambridge University Hospitals
- Lurie Children's
- Newlife IVF
- Cancer Council
- Avisena Healthcare
- Kofinas Fertility Group
- Loma Linda University Center for Fertility & IVF
- Livestrong
- Melbourne IVF
- St. Luke's Medical Centre
- Manhattan Reproductive Surgery Center
- Biomedical Research Centre
- Guy's and St Thomas' Private Healthcare
- ReproTech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Ovarian Tissue Cryopreservation Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Ovary Tissue Removal
- 2.2.3 Ovarian Tissue Cryopreservation
- 2.2.4 Ovarian Tissue Reimplantation
- 2.3 Ovarian Tissue Cryopreservation Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Individual
- 2.3.3 Family
- 2.4 Assumptions and Limitations
3 Ovarian Tissue Cryopreservation Service Breakdown Data by Type
- 3.1 Global Ovarian Tissue Cryopreservation Service Historic Market Size by Type (2021-2026)
- 3.2 Global Ovarian Tissue Cryopreservation Service Forecasted Market Size by Type (2027-2032)
4 Ovarian Tissue Cryopreservation Service Breakdown Data by Application
- 4.1 Global Ovarian Tissue Cryopreservation Service Historic Market Size by Application (2021-2026)
- 4.2 Global Ovarian Tissue Cryopreservation Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Ovarian Tissue Cryopreservation Service Market Perspective (2021-2032)
- 5.2 Global Ovarian Tissue Cryopreservation Service Growth Trends by Region
- 5.2.1 Global Ovarian Tissue Cryopreservation Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Ovarian Tissue Cryopreservation Service Historic Market Size by Region (2021-2026)
- 5.2.3 Ovarian Tissue Cryopreservation Service Forecasted Market Size by Region (2027-2032)
- 5.3 Ovarian Tissue Cryopreservation Service Market Dynamics
- 5.3.1 Ovarian Tissue Cryopreservation Service Industry Trends
- 5.3.2 Ovarian Tissue Cryopreservation Service Market Drivers
- 5.3.3 Ovarian Tissue Cryopreservation Service Market Challenges
- 5.3.4 Ovarian Tissue Cryopreservation Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Ovarian Tissue Cryopreservation Service Players by Revenue
- 6.1.1 Global Top Ovarian Tissue Cryopreservation Service Players by Revenue (2021-2026)
- 6.1.2 Global Ovarian Tissue Cryopreservation Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Ovarian Tissue Cryopreservation Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Ovarian Tissue Cryopreservation Service Head Office and Area Served
- 6.4 Global Ovarian Tissue Cryopreservation Service Players, Product Type & Application
- 6.5 Global Ovarian Tissue Cryopreservation Service Manufacturers Established Date
- 6.6 Global Ovarian Tissue Cryopreservation Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Ovarian Tissue Cryopreservation Service Market Size (2021-2032)
- 7.2 North America Ovarian Tissue Cryopreservation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Ovarian Tissue Cryopreservation Service Market Size by Country (2021-2026)
- 7.4 North America Ovarian Tissue Cryopreservation Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Ovarian Tissue Cryopreservation Service Market Size (2021-2032)
- 8.2 Europe Ovarian Tissue Cryopreservation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Ovarian Tissue Cryopreservation Service Market Size by Country (2021-2026)
- 8.4 Europe Ovarian Tissue Cryopreservation Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Ovarian Tissue Cryopreservation Service Market Size (2021-2032)
- 9.2 Asia-Pacific Ovarian Tissue Cryopreservation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Ovarian Tissue Cryopreservation Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Ovarian Tissue Cryopreservation Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Ovarian Tissue Cryopreservation Service Market Size (2021-2032)
- 10.2 South America Ovarian Tissue Cryopreservation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Ovarian Tissue Cryopreservation Service Market Size by Country (2021-2026)
- 10.4 South America Ovarian Tissue Cryopreservation Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Ovarian Tissue Cryopreservation Service Market Size (2021-2032)
- 11.2 Middle East & Africa Ovarian Tissue Cryopreservation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Ovarian Tissue Cryopreservation Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Ovarian Tissue Cryopreservation Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Cambridge University Hospitals
- 12.1.1 Cambridge University Hospitals Company Information
- 12.1.2 Cambridge University Hospitals Business Overview
- 12.1.3 Cambridge University Hospitals Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.1.4 Cambridge University Hospitals Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.1.5 Cambridge University Hospitals Recent Developments
- 12.2 Lurie Children's
- 12.2.1 Lurie Children's Company Information
- 12.2.2 Lurie Children's Business Overview
- 12.2.3 Lurie Children's Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.2.4 Lurie Children's Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.2.5 Lurie Children's Recent Developments
- 12.3 Newlife IVF
- 12.3.1 Newlife IVF Company Information
- 12.3.2 Newlife IVF Business Overview
- 12.3.3 Newlife IVF Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.3.4 Newlife IVF Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.3.5 Newlife IVF Recent Developments
- 12.4 Cancer Council
- 12.4.1 Cancer Council Company Information
- 12.4.2 Cancer Council Business Overview
- 12.4.3 Cancer Council Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.4.4 Cancer Council Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.4.5 Cancer Council Recent Developments
- 12.5 Avisena Healthcare
- 12.5.1 Avisena Healthcare Company Information
- 12.5.2 Avisena Healthcare Business Overview
- 12.5.3 Avisena Healthcare Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.5.4 Avisena Healthcare Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.5.5 Avisena Healthcare Recent Developments
- 12.6 Kofinas Fertility Group
- 12.6.1 Kofinas Fertility Group Company Information
- 12.6.2 Kofinas Fertility Group Business Overview
- 12.6.3 Kofinas Fertility Group Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.6.4 Kofinas Fertility Group Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.6.5 Kofinas Fertility Group Recent Developments
- 12.7 Loma Linda University Center for Fertility & IVF
- 12.7.1 Loma Linda University Center for Fertility & IVF Company Information
- 12.7.2 Loma Linda University Center for Fertility & IVF Business Overview
- 12.7.3 Loma Linda University Center for Fertility & IVF Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.7.4 Loma Linda University Center for Fertility & IVF Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.7.5 Loma Linda University Center for Fertility & IVF Recent Developments
- 12.8 Livestrong
- 12.8.1 Livestrong Company Information
- 12.8.2 Livestrong Business Overview
- 12.8.3 Livestrong Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.8.4 Livestrong Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.8.5 Livestrong Recent Developments
- 12.9 Melbourne IVF
- 12.9.1 Melbourne IVF Company Information
- 12.9.2 Melbourne IVF Business Overview
- 12.9.3 Melbourne IVF Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.9.4 Melbourne IVF Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.9.5 Melbourne IVF Recent Developments
- 12.10 St. Luke's Medical Centre
- 12.10.1 St. Luke's Medical Centre Company Information
- 12.10.2 St. Luke's Medical Centre Business Overview
- 12.10.3 St. Luke's Medical Centre Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.10.4 St. Luke's Medical Centre Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.10.5 St. Luke's Medical Centre Recent Developments
- 12.11 Manhattan Reproductive Surgery Center
- 12.11.1 Manhattan Reproductive Surgery Center Company Information
- 12.11.2 Manhattan Reproductive Surgery Center Business Overview
- 12.11.3 Manhattan Reproductive Surgery Center Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.11.4 Manhattan Reproductive Surgery Center Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.11.5 Manhattan Reproductive Surgery Center Recent Developments
- 12.12 Biomedical Research Centre
- 12.12.1 Biomedical Research Centre Company Information
- 12.12.2 Biomedical Research Centre Business Overview
- 12.12.3 Biomedical Research Centre Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.12.4 Biomedical Research Centre Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.12.5 Biomedical Research Centre Recent Developments
- 12.13 Guy's and St Thomas' Private Healthcare
- 12.13.1 Guy's and St Thomas' Private Healthcare Company Information
- 12.13.2 Guy's and St Thomas' Private Healthcare Business Overview
- 12.13.3 Guy's and St Thomas' Private Healthcare Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.13.4 Guy's and St Thomas' Private Healthcare Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.13.5 Guy's and St Thomas' Private Healthcare Recent Developments
- 12.14 ReproTech
- 12.14.1 ReproTech Company Information
- 12.14.2 ReproTech Business Overview
- 12.14.3 ReproTech Revenue in Ovarian Tissue Cryopreservation Service Business (2021-2026)
- 12.14.4 ReproTech Ovarian Tissue Cryopreservation Service Product Portfolio
- 12.14.5 ReproTech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst